These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 19403460)

  • 1. Pharmacogenetics of antidepressant response: an update.
    Drago A; De Ronchi D; Serretti A
    Hum Genomics; 2009 Apr; 3(3):257-74. PubMed ID: 19403460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review and meta-analysis of antidepressant pharmacogenetic findings in major depressive disorder.
    Kato M; Serretti A
    Mol Psychiatry; 2010 May; 15(5):473-500. PubMed ID: 18982004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of serotonin-related genes affects short-term antidepressant response in major depressive disorder.
    Lin E; Chen PS; Chang HH; Gean PW; Tsai HC; Yang YK; Lu RB
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Oct; 33(7):1167-72. PubMed ID: 19560507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenetics in major depression: a comprehensive meta-analysis.
    Niitsu T; Fabbri C; Bentini F; Serretti A
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():183-94. PubMed ID: 23733030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insights and barriers to clinical use of serotonin transporter pharmacogenetics in antidepressant therapy.
    Stevenson JM
    Pharmacogenomics; 2018 Feb; 19(3):167-170. PubMed ID: 29325499
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacogenetics and Imaging-Pharmacogenetics of Antidepressant Response: Towards Translational Strategies.
    Lett TA; Walter H; Brandl EJ
    CNS Drugs; 2016 Dec; 30(12):1169-1189. PubMed ID: 27752945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain-derived neurotrophic factor and antidepressant action: another piece of evidence from pharmacogenetics.
    Tsai SJ; Hong CJ; Liou YJ
    Pharmacogenomics; 2008 Sep; 9(9):1353-8. PubMed ID: 18781861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetics and personalized medicine in antidepressant treatment.
    Gvozdic K; Brandl EJ; Taylor DL; Müller DJ
    Curr Pharm Des; 2012; 18(36):5853-78. PubMed ID: 22681166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From pharmacogenetics to imaging pharmacogenetics: elucidating mechanisms of antidepressant response.
    Brandl EJ; Walter H
    Pharmacogenomics; 2017 Jul; 18(10):927-930. PubMed ID: 28639501
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacogenetics and the serotonin transporter in late-life depression.
    Gerretsen P; Pollock BG
    Expert Opin Drug Metab Toxicol; 2008 Dec; 4(12):1465-78. PubMed ID: 19040324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenetics of antidepressant treatment in obsessive-compulsive disorder: an update and implications for clinicians.
    Zai G; Brandl EJ; Müller DJ; Richter MA; Kennedy JL
    Pharmacogenomics; 2014 Jun; 15(8):1147-57. PubMed ID: 25084207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequence variations of ABCB1, SLC6A2, SLC6A3, SLC6A4, CREB1, CRHR1 and NTRK2: association with major depression and antidepressant response in Mexican-Americans.
    Dong C; Wong ML; Licinio J
    Mol Psychiatry; 2009 Dec; 14(12):1105-18. PubMed ID: 19844206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leveraging genetics to enhance the efficacy of PTSD pharmacotherapies.
    Miller MW
    Neurosci Lett; 2020 May; 726():133562. PubMed ID: 29689343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenetics of antidepressive treatment.
    Zobel A; Maier W
    Eur Arch Psychiatry Clin Neurosci; 2010 Aug; 260(5):407-17. PubMed ID: 20047055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From pharmacogenetics to pharmacogenomics: the way toward the personalization of antidepressant treatment.
    Fabbri C; Porcelli S; Serretti A
    Can J Psychiatry; 2014 Feb; 59(2):62-75. PubMed ID: 24881125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corticotropin releasing hormone receptor CRHR1 gene is associated with tianeptine antidepressant response in a large sample of outpatients from real-life settings.
    Ramoz N; Hoertel N; Nobile B; Voegeli G; Nasr A; Le Strat Y; Courtet P; Gorwood P
    Transl Psychiatry; 2020 Nov; 10(1):378. PubMed ID: 33154348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacogenetics studies in STAR*D: strengths, limitations, and results.
    Laje G; Perlis RH; Rush AJ; McMahon FJ
    Psychiatr Serv; 2009 Nov; 60(11):1446-57. PubMed ID: 19880459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of Serotonin Transporter Promoter Polymorphism (SERTPR) and other polymorphisms of the serotonin pathway on the efficacy of antidepressant treatments.
    Serretti A; Benedetti F; Zanardi R; Smeraldi E
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jul; 29(6):1074-84. PubMed ID: 15939518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FKBP5 Gene Expression Predicts Antidepressant Treatment Outcome in Depression.
    Ising M; Maccarrone G; Brückl T; Scheuer S; Hennings J; Holsboer F; Turck CW; Uhr M; Lucae S
    Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30678080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding the pharmacogenetics of selective serotonin reuptake inhibitors.
    Fabbri C; Minarini A; Niitsu T; Serretti A
    Expert Opin Drug Metab Toxicol; 2014 Aug; 10(8):1093-118. PubMed ID: 24930681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.